Hideaki Takahashi

Loss of p53 drives neuron reprogramming in head and neck cancer

Moran Amit, Hideaki Takahashi, Mihnea P. Dragomir et al. · Nature · 2020 · 453 citations · Full text

Medicine, Cancer Biology, Oncology +10

Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Salivary Duct Carcinoma

Hideaki Takahashi, Yuichiro Tada, Takashi Saotome et al. · Journal of Clinical Oncology · 2018 · 256 citations

Medicine, Oncology, Pharmacology +15

Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy

Tao Jiang, Xiaoxin X. Wang, Pnina Scherzer et al. · Diabetes · 2007 · 232 citations · Full text

Medicine, Endocrinology, Pharmacology +17

A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma

C. Fushimi, Yuichiro Tada, Hideaki Takahashi et al. · Annals of Oncology · 2017 · 220 citations · Full text

Medicine, Oncology, Pharmacology +13

Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma

Moran Amit, Ahmed S. Abdelmeguid, Teemaranawich Watcherporn et al. · Journal of Clinical Oncology · 2019 · 171 citations · Full text

Medicine, Oncology, Chemotherapy +15